SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
Alliance4Growth, an Advisory and Transactional Consulting Firm, Ann...            http://www.businesswire.com/news/home/20120615005728/en/Allian...




          June 15, 2012 12:46 PM Eastern Daylight Time


                 Alliance4Growth, an Advisory and Transactional Consulting Firm, Announces Its
                                           Participation to BIO 2012

              Four Life Sciences veterans bring to bear a new approach in the strategic international advisory field for highly
                                                    innovative life sciences companies

          2012 BIO International Convention

          PARIS & PITTSBURGH--(BUSINESS WIRE)--The recently formed strategic, transactional and operational advisory firm,
          Alliance4Growth (A4G), is pleased to announce its participation to the BIO US conference, a premier venue in the Life Sciences
          and Biotechnology arenas, in support to its endeavors with a variety of clients.

          Dr. Bernard Cambou, Managing Partner – US Office, who resides in the United States since               “The life sciences arena is
          1995, will attend this important conference to initiate various partnering initiatives in support to
                                                                                                                 rapidly changing and the
          clients’ international development initiatives.
                                                                                                                 “going alone”
          “Traditional venture investing is a thing of the past”

          “The life sciences arena is rapidly changing and the “going alone” model of the past does not apply anymore” says Dr. Gilles
          Avenard, Managing Partner. He stresses that “in a complex, challenging and ever-changing financial and industrial
          environment, the biotechnology and pharmaceutical companies are more and more looking for partners to sustain their growth
          and remain at the cutting-edge in this very competitive and fully globalised field. Our core expertise is to advise them and act
          upon innovative solutions that create both industrial and financial perspectives. We believe that the long term viability of highly
          innovative companies, today more than ever, requires means to establish value of the assets, secure alliances, and reach
          critical size at an earlier stage”.

          A synergistic array of competencies

          Thanks to the combined competencies of its 4 original founders, A4G is well-equipped to intervene in most if not all aspects that
          relate to growth, monetization of assets as well as operational risk-mitigation in the life sciences, biotechnology and
          pharmaceutical sectors. Typical assignments that A4G is conducting today are:

          - R&D, industrial and commercial partnering in various geographies

          - Clinical/regulatory strategy

          - Monetization of broad patent portfolio

          - Financings

          - Asset disposal

          - Buy-out

          - Licensing

          - Implementation of a US-based commercial and operational business

          A4G at a glance:




1 sur 2                                                                                                                                16/06/2012 17:53
Alliance4Growth, an Advisory and Transactional Consulting Firm, Ann...         http://www.businesswire.com/news/home/20120615005728/en/Allian...


          Alliance4growth is a strategic advice firm dedicated to the field of innovative pharmaceutical and medical technology solutions.
          Alliance4Growth is headquartered in Paris, France. It operates in the US from its office in Pittsburgh, PA.

          Contacts

          Alliance4Growth
          Bernard Cambou, PhD, MBA, +1 412 567 0434
          +1 412 551 2665
          Managing Partner - US Office
          bernard@alliance4growth.com
          www.alliance4growth.com
          or
          Acorelis
          Gilles Petitot, 00 33 6 20 27 65 94
          gilles.petitot@acorelis.com




2 sur 2                                                                                                                              16/06/2012 17:53

Contenu connexe

Similaire à Alliance4 Growth, An Advisory And Transactional Consulting Firm, Announces Its Participation To Bio 2012

leaflet BioNautilus 2pages-juillet 2016
leaflet BioNautilus 2pages-juillet 2016leaflet BioNautilus 2pages-juillet 2016
leaflet BioNautilus 2pages-juillet 2016Philippe Grandjean
 
Kantar_Health_brand_guidelines_Feb2012
Kantar_Health_brand_guidelines_Feb2012Kantar_Health_brand_guidelines_Feb2012
Kantar_Health_brand_guidelines_Feb2012eSeidr
 
2014 Biopharmaceutical Partnering Survey
2014 Biopharmaceutical Partnering Survey2014 Biopharmaceutical Partnering Survey
2014 Biopharmaceutical Partnering SurveyBoston Consulting Group
 
HealthXL 2014
HealthXL 2014HealthXL 2014
HealthXL 2014Health_XL
 
HealthXL 2014
HealthXL 2014HealthXL 2014
HealthXL 2014Health_XL
 
NHP - Mondias Naturals Fact Sheet - Jan. 2019
NHP - Mondias Naturals Fact Sheet - Jan. 2019NHP - Mondias Naturals Fact Sheet - Jan. 2019
NHP - Mondias Naturals Fact Sheet - Jan. 2019MomentumPR
 
Early asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for successEarly asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for successCello Health
 
Our Specialisms - USA
Our Specialisms - USAOur Specialisms - USA
Our Specialisms - USASummerColes
 
5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) Pp5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) PpPiyush Patel
 
Driving Revenue Growth Through Sustainable Products and Services
Driving Revenue Growth Through Sustainable Products and ServicesDriving Revenue Growth Through Sustainable Products and Services
Driving Revenue Growth Through Sustainable Products and ServicesSustainable Brands
 
11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)shad121
 
NHP - Mondias Investor Presentation - December 2018
NHP - Mondias Investor Presentation - December 2018NHP - Mondias Investor Presentation - December 2018
NHP - Mondias Investor Presentation - December 2018MomentumPR
 
Why this Venturing Executive from 3 of the largest food multinationals launch...
Why this Venturing Executive from 3 of the largest food multinationals launch...Why this Venturing Executive from 3 of the largest food multinationals launch...
Why this Venturing Executive from 3 of the largest food multinationals launch...Gil Horsky
 
Pfizer strategy for internationalization
Pfizer strategy for internationalizationPfizer strategy for internationalization
Pfizer strategy for internationalizationAamir chouhan
 

Similaire à Alliance4 Growth, An Advisory And Transactional Consulting Firm, Announces Its Participation To Bio 2012 (20)

leaflet BioNautilus 2pages-juillet 2016
leaflet BioNautilus 2pages-juillet 2016leaflet BioNautilus 2pages-juillet 2016
leaflet BioNautilus 2pages-juillet 2016
 
Kantar_Health_brand_guidelines_Feb2012
Kantar_Health_brand_guidelines_Feb2012Kantar_Health_brand_guidelines_Feb2012
Kantar_Health_brand_guidelines_Feb2012
 
2014 Biopharmaceutical Partnering Survey
2014 Biopharmaceutical Partnering Survey2014 Biopharmaceutical Partnering Survey
2014 Biopharmaceutical Partnering Survey
 
HealthXL 2014
HealthXL 2014HealthXL 2014
HealthXL 2014
 
HealthXL 2014
HealthXL 2014HealthXL 2014
HealthXL 2014
 
NHP - Mondias Naturals Fact Sheet - Jan. 2019
NHP - Mondias Naturals Fact Sheet - Jan. 2019NHP - Mondias Naturals Fact Sheet - Jan. 2019
NHP - Mondias Naturals Fact Sheet - Jan. 2019
 
The Bridgehead Group
The Bridgehead GroupThe Bridgehead Group
The Bridgehead Group
 
Bridgehead credentials slide deck
Bridgehead credentials slide deckBridgehead credentials slide deck
Bridgehead credentials slide deck
 
The Pharma Partners - Introduction
The Pharma Partners - IntroductionThe Pharma Partners - Introduction
The Pharma Partners - Introduction
 
SHRIJI POLYMERS COMPANY PROFILE
SHRIJI POLYMERS COMPANY PROFILESHRIJI POLYMERS COMPANY PROFILE
SHRIJI POLYMERS COMPANY PROFILE
 
Early asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for successEarly asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for success
 
PSL Company Brochure
PSL Company BrochurePSL Company Brochure
PSL Company Brochure
 
Our Specialisms - USA
Our Specialisms - USAOur Specialisms - USA
Our Specialisms - USA
 
5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) Pp5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) Pp
 
Driving Revenue Growth Through Sustainable Products and Services
Driving Revenue Growth Through Sustainable Products and ServicesDriving Revenue Growth Through Sustainable Products and Services
Driving Revenue Growth Through Sustainable Products and Services
 
11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)
 
NHP - Mondias Investor Presentation - December 2018
NHP - Mondias Investor Presentation - December 2018NHP - Mondias Investor Presentation - December 2018
NHP - Mondias Investor Presentation - December 2018
 
Why this Venturing Executive from 3 of the largest food multinationals launch...
Why this Venturing Executive from 3 of the largest food multinationals launch...Why this Venturing Executive from 3 of the largest food multinationals launch...
Why this Venturing Executive from 3 of the largest food multinationals launch...
 
Aagami Consutling
Aagami ConsutlingAagami Consutling
Aagami Consutling
 
Pfizer strategy for internationalization
Pfizer strategy for internationalizationPfizer strategy for internationalization
Pfizer strategy for internationalization
 

Plus de christiangirard

BIOTECHFINANCES_N_742_COVER
BIOTECHFINANCES_N_742_COVERBIOTECHFINANCES_N_742_COVER
BIOTECHFINANCES_N_742_COVERchristiangirard
 
Conférence Centrale - Essec Santé - 11042016
Conférence Centrale - Essec Santé - 11042016Conférence Centrale - Essec Santé - 11042016
Conférence Centrale - Essec Santé - 11042016christiangirard
 
grants4od.fund presentation
grants4od.fund presentationgrants4od.fund presentation
grants4od.fund presentationchristiangirard
 
CHRISTIAN GIRARD PRESENTATION LONDON 20150629
CHRISTIAN GIRARD PRESENTATION LONDON 20150629CHRISTIAN GIRARD PRESENTATION LONDON 20150629
CHRISTIAN GIRARD PRESENTATION LONDON 20150629christiangirard
 
Biotech Finances Article MéDicaments Orphelins
Biotech Finances Article MéDicaments OrphelinsBiotech Finances Article MéDicaments Orphelins
Biotech Finances Article MéDicaments Orphelinschristiangirard
 
A4G Article in Biotech Finances 529
A4G Article in Biotech Finances 529A4G Article in Biotech Finances 529
A4G Article in Biotech Finances 529christiangirard
 

Plus de christiangirard (6)

BIOTECHFINANCES_N_742_COVER
BIOTECHFINANCES_N_742_COVERBIOTECHFINANCES_N_742_COVER
BIOTECHFINANCES_N_742_COVER
 
Conférence Centrale - Essec Santé - 11042016
Conférence Centrale - Essec Santé - 11042016Conférence Centrale - Essec Santé - 11042016
Conférence Centrale - Essec Santé - 11042016
 
grants4od.fund presentation
grants4od.fund presentationgrants4od.fund presentation
grants4od.fund presentation
 
CHRISTIAN GIRARD PRESENTATION LONDON 20150629
CHRISTIAN GIRARD PRESENTATION LONDON 20150629CHRISTIAN GIRARD PRESENTATION LONDON 20150629
CHRISTIAN GIRARD PRESENTATION LONDON 20150629
 
Biotech Finances Article MéDicaments Orphelins
Biotech Finances Article MéDicaments OrphelinsBiotech Finances Article MéDicaments Orphelins
Biotech Finances Article MéDicaments Orphelins
 
A4G Article in Biotech Finances 529
A4G Article in Biotech Finances 529A4G Article in Biotech Finances 529
A4G Article in Biotech Finances 529
 

Alliance4 Growth, An Advisory And Transactional Consulting Firm, Announces Its Participation To Bio 2012

  • 1. Alliance4Growth, an Advisory and Transactional Consulting Firm, Ann... http://www.businesswire.com/news/home/20120615005728/en/Allian... June 15, 2012 12:46 PM Eastern Daylight Time Alliance4Growth, an Advisory and Transactional Consulting Firm, Announces Its Participation to BIO 2012 Four Life Sciences veterans bring to bear a new approach in the strategic international advisory field for highly innovative life sciences companies 2012 BIO International Convention PARIS & PITTSBURGH--(BUSINESS WIRE)--The recently formed strategic, transactional and operational advisory firm, Alliance4Growth (A4G), is pleased to announce its participation to the BIO US conference, a premier venue in the Life Sciences and Biotechnology arenas, in support to its endeavors with a variety of clients. Dr. Bernard Cambou, Managing Partner – US Office, who resides in the United States since “The life sciences arena is 1995, will attend this important conference to initiate various partnering initiatives in support to rapidly changing and the clients’ international development initiatives. “going alone” “Traditional venture investing is a thing of the past” “The life sciences arena is rapidly changing and the “going alone” model of the past does not apply anymore” says Dr. Gilles Avenard, Managing Partner. He stresses that “in a complex, challenging and ever-changing financial and industrial environment, the biotechnology and pharmaceutical companies are more and more looking for partners to sustain their growth and remain at the cutting-edge in this very competitive and fully globalised field. Our core expertise is to advise them and act upon innovative solutions that create both industrial and financial perspectives. We believe that the long term viability of highly innovative companies, today more than ever, requires means to establish value of the assets, secure alliances, and reach critical size at an earlier stage”. A synergistic array of competencies Thanks to the combined competencies of its 4 original founders, A4G is well-equipped to intervene in most if not all aspects that relate to growth, monetization of assets as well as operational risk-mitigation in the life sciences, biotechnology and pharmaceutical sectors. Typical assignments that A4G is conducting today are: - R&D, industrial and commercial partnering in various geographies - Clinical/regulatory strategy - Monetization of broad patent portfolio - Financings - Asset disposal - Buy-out - Licensing - Implementation of a US-based commercial and operational business A4G at a glance: 1 sur 2 16/06/2012 17:53
  • 2. Alliance4Growth, an Advisory and Transactional Consulting Firm, Ann... http://www.businesswire.com/news/home/20120615005728/en/Allian... Alliance4growth is a strategic advice firm dedicated to the field of innovative pharmaceutical and medical technology solutions. Alliance4Growth is headquartered in Paris, France. It operates in the US from its office in Pittsburgh, PA. Contacts Alliance4Growth Bernard Cambou, PhD, MBA, +1 412 567 0434 +1 412 551 2665 Managing Partner - US Office bernard@alliance4growth.com www.alliance4growth.com or Acorelis Gilles Petitot, 00 33 6 20 27 65 94 gilles.petitot@acorelis.com 2 sur 2 16/06/2012 17:53